Literature DB >> 21506277

Inhibitors of the interactions between HIV-1 IN and the cofactor LEDGF/p75.

Laura De Luca1, Stefania Ferro, Francesca Morreale, Sara De Grazia, Alba Chimirri.   

Abstract

The replication cycle of human immunodeficiency virus type 1 (HIV-1) is a complex multistep process that depends on both viral and host cell factors. The nuclear protein lens epithelium-derived growth factor (LEDGF/p75) is a multidomain protein, present in host cells, which plays an important role in the integration process. LEDGF/p75 not only binds HIV-1 integrase (IN) at its IN binding domain (IBD) but also contains several motifs that function in DNA and chromatin binding. The demonstrated importance of the association between IN and LEDGF/p75 in HIV-1 integration suggests the possibility that this protein-protein interaction (PPI) could be exploited as an antiviral target. We describe herein the progress to date in developing inhibitors of this promising target.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21506277     DOI: 10.1002/cmdc.201100071

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  12 in total

1.  HIV Drug Resistance and the Advent of Integrase Inhibitors.

Authors:  Peter K Quashie; Thibault Mesplède; Mark A Wainberg
Journal:  Curr Infect Dis Rep       Date:  2013-02       Impact factor: 3.725

2.  Identification of old drugs as potential inhibitors of HIV-1 integrase - human LEDGF/p75 interaction via molecular docking.

Authors:  Guoping Hu; Xi Li; Xianqiang Sun; Weiqiang Lu; Guixia Liu; Jin Huang; Xu Shen; Yun Tang
Journal:  J Mol Model       Date:  2012-06-26       Impact factor: 1.810

Review 3.  Small-molecule inhibitors of protein-protein interactions: progressing toward the reality.

Authors:  Michelle R Arkin; Yinyan Tang; James A Wells
Journal:  Chem Biol       Date:  2014-09-18

4.  The molecular biology of HIV integrase.

Authors:  Robert Craigie
Journal:  Future Virol       Date:  2012-07       Impact factor: 1.831

5.  Fragment-based discovery of 8-hydroxyquinoline inhibitors of the HIV-1 integrase-lens epithelium-derived growth factor/p75 (IN-LEDGF/p75) interaction.

Authors:  Erik Serrao; Bikash Debnath; Hiroyuki Otake; Yuting Kuang; Frauke Christ; Zeger Debyser; Nouri Neamati
Journal:  J Med Chem       Date:  2013-03-18       Impact factor: 7.446

6.  Interrogating HIV integrase for compounds that bind--a SAMPL challenge.

Authors:  Thomas S Peat; Olan Dolezal; Janet Newman; David Mobley; John J Deadman
Journal:  J Comput Aided Mol Des       Date:  2014-02-16       Impact factor: 3.686

7.  Small molecule inhibitors of the LEDGF site of human immunodeficiency virus integrase identified by fragment screening and structure based design.

Authors:  Thomas S Peat; David I Rhodes; Nick Vandegraaff; Giang Le; Jessica A Smith; Lisa J Clark; Eric D Jones; Jonathan A V Coates; Neeranat Thienthong; Janet Newman; Olan Dolezal; Roger Mulder; John H Ryan; G Paul Savage; Craig L Francis; John J Deadman
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

Review 8.  Novel therapeutic strategies targeting HIV integrase.

Authors:  Peter K Quashie; Richard D Sloan; Mark A Wainberg
Journal:  BMC Med       Date:  2012-04-12       Impact factor: 8.775

Review 9.  The paramyxovirus polymerase complex as a target for next-generation anti-paramyxovirus therapeutics.

Authors:  Robert Cox; Richard K Plemper
Journal:  Front Microbiol       Date:  2015-05-12       Impact factor: 5.640

10.  Structural Studies of the HIV-1 Integrase Protein: Compound Screening and Characterization of a DNA-Binding Inhibitor.

Authors:  Peter K Quashie; Ying-Shan Han; Said Hassounah; Thibault Mesplède; Mark A Wainberg
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.